Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

Biotechnology

Healthcare
$1.72 -2.64%

-$0.05 today

Market cap
$765.80M
Beta
1.07
P/E (TTM)
-30.5
EPS (TTM)
-$0.07
52W Low $0.71High $2.53

Volume 2.02M

Average 2.48M

Balance Sheet

Inspect the capital base behind the business.

Assets

$184.99M

FY 2025 · Annual

-38.0% YoY

Liabilities

$77.45M

FY 2025 · Annual

-49.2% YoY

Equity

$107.54M

FY 2025 · Annual

-26.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents64.07M46.35M22.47M66.66M34.33M
Short-term Investments22.68M92.01M147.56M171.3M61.9M
Net Receivables14K28K1.01M3.47M2.38M
Inventory00381K231K281K
Other Current Assets02.48M5.13M4.53M3M
Total Current Assets88.92M140.87M176.55M246.19M101.9M
Property, Plant & Equipment (Net)3.45M8.48M7.51M7.32M9.18M
Goodwill44.54M44.54M44.54M44.54M44.54M
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0412K828K368K29.37M
Total Non-current Assets47.99M53.43M52.88M52.23M83.09M
Total Assets136.91M194.3M229.43M298.42M184.99M
Account Payables9.15M10.4M14.39M14.8M3.08M
Short-term Debt00006.24M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities5.71M3.66M9.59M14.71M5.13M
Total Current Liabilities22.12M23.17M31.55M45.25M20.87M
Long-term Debt048.58M99.51M100.3M49.41M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000582K
Total Non-current Liabilities1.19M54M104.77M107.22M56.58M
Total Liabilities23.31M77.18M136.32M152.47M77.45M
Common Stock150K189K245K363K366K
Retained Earnings(1.49B)(1.59B)(1.77B)(1.97B)(2.02B)
Accumulated OCI(10K)(428K)31K119K30K
Other Stockholders Equity00000
Minority Interest00000
Total Equity113.6M117.12M93.11M145.95M107.54M
Total Debt2.28M55.29M106.06M108.4M62.24M
Net Debt(61.79M)8.95M83.6M41.74M27.91M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$38.1M
Short-term Investments$132.6M
Receivables$11.8M
Inventory$276.0K
Other Current$3.3M
Total Current Assets$186.0M
PP&E (Net)$8.9M
Goodwill$44.5M
Other Non-current$29.4M
Total Non-current Assets$82.8M
Total Assets$268.8M

Analysis

Selected assets total $268.8M for Latest. The largest visible component is Short-term Investments at $132.6M, about 49.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
EFFECTEFFECT filingAug 14, 2026

How much cash does LXRX have?

Lexicon Pharmaceuticals, Inc. (LXRX) reported $34.33M in cash and equivalents in fiscal 2025.

How much debt does LXRX carry?

Lexicon Pharmaceuticals, Inc. (LXRX) reported $62.24M of total debt, with net debt of $27.91M.